@PassportCan can I drop off my application at one of your offices in a secure mailbox on site ? I am hesitant to courier and am too busy to line up to see an agent. Can I drop off?
A special message from YVR CEO Craig Richmond to @KellyRipa. Quote tweet this and tag Kelly for a chance to win a $500 shopping spree at any one of YVR’s incredible shopping outlets. #LiveWithKellyAndCraig
It was a privilege to be part of the 3rd annual TELUS Health Executive Roundtable today. Lots of insightful discussion around what the future in health benefit plans will look like and ideas on how best to provide value to employees.
@tdsb my street is still not plowed well enough for my son’s school bus to navigate through it (or surrounding streets either). Will busses be cancelled today? (Wednesday)? (Worried mom)
@AlexanderWangNY I’m not impressed with the way @HoltRenfrew has treated me. I have a new pair of your booties: the heel is peeling off both boots. I adore them and have wore them only 6 or so times. I feel they should be replaced. Holts was quite difficult- I await an answer.
Great article from @BenCanMag that perfectly summarizes why we've partnered with telemedicine option @GOeVisit to bring easier access to medical professionals to Canadians. Definitely an emerging trend in the market! https://t.co/zB7nGUDYV1
@DaysInnCanada very surprised no flexibility whatsoever on my request for late check out. Sick child needs to sleep a bit longer and zero desire to support me even for an extra 30 mins - after a 3 night stay. Too bad!
Join me on Feb 27 in Toronto for the Employers Cancer Care Summit @BenCanMag hosts this important annual event. Visit https://t.co/yyKdVsVlOt to register !
Francesca Allman, Benefits Canada thanks for choosing me to be part of Canada’s Leadership Council for Drug Plan Partnership. We didn’t solve Canada’s Pharmacare troubles but we sure tried. #benefitscanada#benefitsalliance https://t.co/J1L3B1fWBC
National pharmacare? @BenCanMag is meeting this afternoon with benefit plan advisors to discuss it. ‘Who pays vs Who administers’ is one part of the complex conversation impacting the future of private drug coverage.